Examining the effect of Melatonin on quality of sleep in Heart failure patients

Examining the effect of Melatonin on quality of sleep in patients with Heart Failure in cardiology clinic of Kosar hospital, Semnan, 2024, a clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241027063510N1

Enrollment

Registered

2024-11-07

Start date

2024-12-07

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure. Heart failure, unspecified

Interventions

Intervention 1: Intervention group: consists of 25 people that in the beginning of the study questionnaire is obtained and after 30 consecutive days of using 3mg melatonin the questionnaire is obtain

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Ejection fraction less than 40%

Exclusion criteria

Exclusion criteria: Constant use of Hypnotic Sedative drugs Major respiratory conditions such as Asthma & COPD Morbid obesity Psychiatric conditions Use of Immunosuppressive drugs

Design outcomes

Primary

Measure	Time frame
?Sleep quality is assessed by PSQI questionnaire, any score above 5 indicates sleep disorder. Timepoint: At the beginning of the study and after 30 days of drug use. Method of measurement: PSQI questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamira Mehrabi Pari

Semnan University of Medical Sciences

drmehrabipari@gmail.com+98 23 3349 0749

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026